Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeNihon Kohden CorporationNihon Kohden Launches Life Scope® SVM-7200 Series Vital Sign Monitor

Nihon Kohden Launches Life Scope® SVM-7200 Series Vital Sign Monitor

The Device is a Portable, Easy-to-Use Monitor with Customizable Early Warning Scoring

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the launch of its Life Scope® SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds that traditionally are not continuously monitored. The monitor allows healthcare practitioners to quickly and easily measure three vital signs – blood oxygen, blood pressure, and temperature.

Part of Nihon Kohden’s complete line of monitors, the Life Scope SVM-7200 provides customizable early warning scoring that helps clinicians identify patients who are deteriorating or at risk of deteriorating by combining vital signs data with observational information. If an at-risk patient is identified, the vital signs monitor can be easily converted to continuous monitoring mode for viewing of vitals within the Nihon Kohden Patient Monitoring System.

“Even patients who seem stable can unexpectedly decline,” said Veffa Devers, DNP, MSHA, RN, CPHQ, vice president of clinical and strategic alliances of Nihon Kohden America. “Most will exhibit gradual changes in vital signs hours before they decline, such as a gradual increase in temperature and heart rate or a subtle, yet progressive change in blood pressure and pulse oximetry. These changes can be a signal that a patient is at risk for a larger health concern, such an infection or hemodynamics decline. Regular and consistent monitoring of vital signs combined with our customizable early warning scoring can help clinicians identify these patients early and intervene before the situation becomes critical.”

The Life Scope SVM-7200 Series vital signs monitor features a high-resolution, 8-inch color touch screen display that enables clinicians to quickly navigate to the information they need. It also includes the company’s pioneering inflation-based non-invasive blood pressure (iNIBP) measure, which automatically detects diastolic and systolic pressure while the cuff is inflating. Rather than inflating the cuff to a preset pressure and measuring blood pressure as the compression is released, Nihon Kohden’s iNIBP cuff inflates only to what is necessary to determine a patient’s blood pressure, making it more comfortable and faster than traditional devices.

Offered with a flexible configuration, the monitor is available with either Nihon Kohden, Nellcor or Masimo SpO2. The monitor also comes standard with wireless functionality, which will be utilized when the planned two-touch send-to-EMR feature is deployed in a few months.

“Our goal is to design monitors that allow clinicians to spend more time with their patients and less time with the technology,” said Yasuhiro Yoshitake, president and CEO of Nihon Kohden America. “With the Life Scope SVM-7200, we have fulfilled this promise. It has an elegant, intuitive design that can be patient-ready in a matter of minutes and can be easily moved from room to room as required. Initial user training for the monitor is easy and can be accomplished in less than an hour, and an on-screen tutorial is available whenever needed.”

The Life Scope SVM-7200 monitor is part of Nihon Kohden’s extensive line of Life Scope monitors, which cover every acuity level. All Nihon Kohden monitors are designed with the company’s premium-as-standard approach, which is based on the philosophy that every patient monitoring feature should be turned on and ready to use at a moment’s notice, and that all software upgrades and updates should be included without any additional charge.

The Life Scope SVM-7200 is crafted using the same exacting quality standards that all Nihon Kohden’s products are known for and is backed by a five-year warranty. The product also comes with 24/7 clinical and technical support, and software upgrades and updates free for the life of the product.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy